Kolexia
Duffaud Florence Oncologie médicale
Duffaud Florence
Oncologie médicale
Hôpital La Timone
Marseille, France
324 Activités
337 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Tumeurs stromales gastro-intestinales Léiomyosarcome Récidive tumorale locale Ostéosarcome Métastase tumorale Fibromatose agressive Tumeurs osseuses Tumeurs des tissus mous

Collaborateurs

Voir plus
Blay Jean Yves
Blay Jean Yves
Centre Léon-Bérard, Lyon, France
Le Cesne Axel
Le Cesne Axel
Gustave-Roussy, Villejuif, France
Penel Nicolas
Penel Nicolas
Centre Oscar-Lambret, Lille, France
Bompas Emmanuelle
Bompas Emmanuelle
Institut de cancérologie de l'Ouest, Saint-Herblain, France

Industries

Voir plus
PUBLICLIN
2 collaboration(s)
Dernière en 2021
DECIPHERA PHARMACEUTICALS (FRANCE) SAS
2 collaboration(s)
Dernière en 2022
Boehringer Ingelheim
2 collaboration(s)
Dernière en 2023
Bayer
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
CRYODESMO-02: A Phase II Multicentric, Randomized Trial Assessing Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting
Essai Clinique (CHU Strasbourg)   15 mars 2024
CHIC-STS01: Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   26 février 2024
ChonDRAgon: A Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma
Essai Clinique (Inhibrx, Inc.)   20 février 2024
COTESARC: A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
Essai Clinique (Centre Léon-Bérard)   09 février 2024
Vismodegib in Treating Patients With Advanced Chondrosarcomas: A Phase 2 Study of GDC-0449 in Patients With Advanced Chondrosarcomas
Essai Clinique (National Cancer Institute)   26 janvier 2024
Improved nationwide survival of sarcoma patients with a network of reference centers.
Annals of oncology : official journal of the European Society for Medical Oncology   19 janvier 2024
CREATE: Cross-tumoral Phase 2 Clinical Trial Exploring Crizotinib (PF-02341066) in Patients With Advanced Tumors Induced by Causal Alterations of ALK and/or MET ("CREATE")
Essai Clinique (Pfizer)   08 décembre 2023
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
European journal of cancer (Oxford, England : 1990)   23 novembre 2023
ASO Visual Abstract: Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial.
Annals of surgical oncology   08 novembre 2023
REGOBONE: A Randomized Phase II, Placebo-controlled, Multicenter Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
Essai Clinique (Unicancer)   06 novembre 2023